SEC 13F Intelligence

Neumeier Poma Investment Counsel LLC / HRMY

Neumeier Poma Investment Counsel LLC’s Harmony Biosciences Hldgs In Position

Does Neumeier Poma Investment Counsel LLC own Harmony Biosciences Hldgs In (HRMY)? Not currently — the last reported position was 595.5K shares worth $20M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$20M
Q3 2023
Shares
595.5K
% of Portfolio
+1.91%
Quarters Held
6
position exited

Position History HRMY

Reported value by quarter
Q2 ’22: $19MQ2 ’22Q3 ’22: $28MQ3 ’22Q4 ’22: $38MQ4 ’22Q1 ’23: $22MQ1 ’23Q2 ’23: $22MQ2 ’23Q3 ’23: $20MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023595.5K$20M+1.91%
Q2 2023636.2K$22M+2.05%
Q1 2023678.7K$22M+2.07%
Q4 2022685.3K$38M+3.51%
Q3 2022636.5K$28M+2.79%
Q2 2022386.3K$19M+1.47%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Neumeier Poma Investment Counsel LLC’s full portfolio or all institutional holders of HRMY.